Childhood Acute Leukemia of Ambiguous Lineage: Clinical Trials

1 trial for Childhood Acute Leukemia of Ambiguous Lineage, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow Childhood Acute Leukemia of Ambiguous Lineage: new trials by email Literature Review of Childhood Acute Leukemia of Ambiguous Lineage trials Research Report on Childhood Acute Leukemia of Ambiguous Lineage

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Acute Leukemia, Acute Leukemia of Ambiguous Lineage
Phase 1RecruitingCity of Hope Medical Center272024-12-312026-10-19

Narrower conditions

Leukemia, Biphenotypic, Acute (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Leukemia (1)  ·  Leukemia, Lymphoid (1)  ·  Leukemia, Myeloid (1)  ·  Lymphatic Diseases (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Interventions

Biopsy (1)  ·  Specimen Handling (1)  ·  revumenib (1)

Sponsors

City of Hope Medical Center (1)

Countries

United States (1)

Top investigators

Brian Ball, MD (1)

NIH funding

P30CA033572 (1)